TABLE 2
Prevalence of IgA anti-TG2 mucosal deposits in the study population
| Patients | Presence of anti-TG2 mucosal deposits | % Positivity |
|---|---|---|
| Type 1 diabetic patients | ||
| TG2+ | 11/14 | 78 |
| TG− | 11/19 | 58 |
| Patients with untreated celiac disease | 12/12 | 100 |
| Control subjects | 4/28 | 14 |
| Patients with IBD | 3/18 | 16.6 |
| Patients with food allergies | 0/9 | 0 |
-
TG2+ type 1 diabetic patients had increased serum levels of anti-TG2 antibodies; TG2− type 1 diabetic patients had normal serum levels of anti-TG2 antibodies.
